Share this post on:

Name :
ACBD4 antibody

Documents :
DataSheet Material Safety Data Sheets (MSDS)

Description :
ACBD4 Rabbit Polyclonal antibody. Positive IF detected in MCF-7 cells. Positive WB detected in human kidney tissue, Transfected HEK-293 cells. Observed molecular weight by Western-blot: 30-38 kDa

Tested applications :
ELISA, WB, IF

Species reactivity :
Human; other species not tested.

Alternative names :
ACBD4 antibody; FLJ13322 antibody; FLJ90623 antibody; HMFT0700 antibody

Immunogen :

Isotype :
Rabbit IgG

Preparation :
This antibody was obtained by immunization of ACBD4 recombinant protein (Accession Number: NM_024722). Purification method: Antigen affinity purified.

Clonality :
Polyclonal

Formulation :
PBS with 0.02% sodium azide and 50% glycerol pH 7.3.

Storage instructions :
Store at -20℃. DO NOT ALIQUOT

Applications :
Recommended Dilution: WB: 1:500-1:5000IF: 1:20-1:200

Background :
ACBD4 represents acyl-Coenzyme A binding domain containing 4

References :

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
MMP9 Antibody
Adiponectin Antibody
CD41 Antibody: CD41 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 113 kDa, targeting to CD41. It can be used for WB,IHC-P assays with tag free, in the background of Human.

Share this post on:

Author: Gardos- Channel